Evidence map›Paper›PMID 39138344›Full record

SynthesisScientific reports2024

Eyelid dermatitis in patch-tested adult patients: a systematic review with a meta-analysis.

Elena Borzova, Elena Snarskaya, Anna Bratkovskaya

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elena BorzovaDermatology Division, Niigata University Graduate School of Medical and Dental Sciences (Medicine), 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan. elena-borzova@med.niigata-u.ac.jp.ORCID 0000-0003-1587-9137
Elena SnarskayaDepartment of Dermatology and Venereology, I.M. Sechenov First Moscow State Medical University, 4/1 Bolshaya Pirogovskaya Street, Moscow, Russian Federation, 119991.ORCID 0000-0002-7968-7663
Anna BratkovskayaDepartment of Dermatology and Venereology, I.M. Sechenov First Moscow State Medical University, 4/1 Bolshaya Pirogovskaya Street, Moscow, Russian Federation, 119991.ORCID 0000-0002-7284-9113

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eyelid dermatitis (ED) affects a cosmetically significant area and leads to patients' distress. Despite ongoing and recent research efforts, ED remains a multidisciplinary problem that needs further characterization. We aimed to evaluate the atopic eyelid dermatitis (AED) frequency in ED patients and to perform their clinical profiling. PubMed databases were searched from 01.01.1980 till 01.02.2024 to PRISMA guidelines using a search strategy: (eyelid OR periorbital OR periocular) AND (dermatitis or eczema). Studies with patch-tested ED patients were included. Proportional meta-analysis was performed using JBI SUMARI software. We included 65 studies across Europe, North America, Asia and Australia, with a total of 21,793 patch-tested ED patients. AED was reported in 27.5% (95% CI 0.177, 0.384) of patch-tested ED patients. Isolated ED was noted in 51.6% (95% CI 0.408, 0.623) of 8453 ED patients with reported lesion distribution, including 430 patients with isolated AED. Our meta-analysis demonstrated that the AED frequency in patch-tested ED patients exceeded the previous estimate of 10%. Isolated AED was noted in adult patients, attending contact allergy clinics. Future studies are needed to elucidate the global prevalence and natural history of isolated AED in adults.

Indexed as

Dermatitis, AtopicEyelid DiseasesPatch TestsAdultDermatitis, Allergic ContactEyelidsFemaleHumansMalePrevalence

Identifiers

PMID39138344
PMCPMC11322306

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.